IKE
Asset Logo

Ikegps Group Limited

πŸ‡¦πŸ‡Ί ASX

πŸ”¨ COMMERCIAL SERVICES & SUPPLIES

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

N/A
Annual Growth

5 years average annual growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

2
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

ikeGPS Group Ltd. engages in the design, sale, and delivery of a solution for the collection, analysis, and management of distribution assets for electric utilities and communications companies. The firm is engaged in design, sale, and delivery of a solution for the collection, analysis, and management of distribution assets for electric utilities and communications companies. The firm provides end-to-end technical solution for customers, it captures and analyses pole loading and make-ready engineering assessments, or customers capture pole data and transact on the platform. The company offers IKE Platform solution where customers use the functionality of IKE Office. The company offers Hardware and other services, such as IKE Device and Spike device sales, and other services including training and deployment. Its solutions include IKE Office Pro, IKE Structural, IKE Insight, IKE Analyze, and IKE University. Its IKE Office Pro is a cloud-based software platform to measure and manage poles quickly, then export them to your native systems.

πŸ“ˆ Performance

Price History

N/A

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.52

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in IKE

2

πŸ“Š Total Capital Earnings

$6K

πŸ”ƒ Average investment frequency

19 weeks

πŸ’΅ Average investment amount

$1,849

⏰ Last time a customer invested in IKE

624 days
IKE investor breakdown
πŸ’΅ Income of investors

More than 200k

50%

150k - 200k

100k - 150k

25%

50k - 100k

Less than 50k

25%
πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

100%
πŸ™‹ Legal gender of investors

Female

Male

100%

Pearlers who invest in IKE also invest in...

Droneshield Limited

DRO

DroneShield Ltd. engages in the development and commercialisation of hardware and software technology for drone detection and security. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-06-22. The company provides artificial intelligence-based platforms for protection against advanced threats, such as drones and autonomous systems. The company offers customers bespoke counter-drone (or counter-UAS) and electronic warfare solutions and off-the-shelf products designed to suit a variety of terrestrial, maritime, or airborne platforms. The Company’s products include DroneGun Tactical, DroneGun MKIII, DroneSentry, DroneSentry-C2, DroneSentry-X, RfPatrol and DroneSim among others. The DroneGun Tactical is an unmanned aerial systems (UAS) countermeasure designed for two-hand operation and long-range defeat. RfPatrol is a passive/non-emitting wearable UAS detection device. The Company’s capabilities include C-UAS, C-UxS Training, and Electronic Warfare.

πŸ™Œ Performance (5Yr p.a)

30.53%

πŸ“Š Share price

$0.72 AUD

πŸš€ AEROSPACE & DEFENSE

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

πŸ™Œ Performance (5Yr p.a)

25.73%

πŸ“Š Share price

$47.45 AUD

πŸ€– TECHNOLOGY

πŸ“ˆ HIGH PRICE GROWTH

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

13.23%

πŸ“Š Share price

$134.96 AUD

🌏 GLOBAL

πŸ€– TECHNOLOGY

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. The firm's principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. The firm's other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users.

πŸ™Œ Performance (5Yr p.a)

-13.79%

πŸ“Š Share price

$0.06 AUD

🩺 HEALTH CARE

Altium Ltd. engages in the development and sale of computer software for the design of electronic products. The company is headquartered in Chatswood, New South Wales. The firm is engaged in the development and sales of computer software for the design of electronic products and an online collaboration platform to facilitate the manufacturing of them. The company focuses on electronics design systems for 3D printed circuit board (PCB) design and embedded system development. The Company’s segments include Design Software and Cloud Platform. The Design Software segment includes printed circuit board (PCB) business for the Americas, Europe, Middle East, Africa (EMEA), China and Asia-Pacific, as well as other products sold through partner channels. The Cloud Platform includes Nexar, Octopart and manufacturing units. Its products include ACTIVEBOM, ActiveRoute, Altium 365, Altium Concord Pro, Altium Designer, Altium NEXUS, Altium Vault, Autotrax, Camtastic, Ciiva, CIIVA SMARTPARTS, CircuitMaker, CircuitStudio, Common Parts Library, Draftsman, DXP, Easytrax, EE Concierge, NanoBoard, NATIVE 3D, OCTOMYZE, and Octopart.

πŸ™Œ Performance (5Yr p.a)

20.86%

πŸ“Š Share price

$68.33 AUD

πŸ€– TECHNOLOGY

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

IKO.AX was created on 2000-05-09 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to provide investors with the performance of the MSCI Korea 25/50 Index, before fees and expenses. The index is designed to measure the performance of Korean large-, mid- & small- capitalisation companies

πŸ™Œ Performance (5Yr p.a)

0.68%

πŸ“Š Share price

$90.24 AUD

⛳️ DIVERSIFIED

πŸ€– TECHNOLOGY

KOREA

Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-04-13. The firm's lead asset is ISLA-101, a drug, being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. The firm operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.

πŸ“Š Share price

$0.17 AUD

πŸ“¦ LOGISTICS

IJP.AX was created on 1996-03-12 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to provide investors with the performance of the MSCI Japan Index, before fees and expenses. The index is designed to measure the performance of Japanese large-, mid- & small- capitalisation companies.

πŸ™Œ Performance (5Yr p.a)

3.66%

πŸ“Š Share price

$104.11 AUD

πŸ‡―πŸ‡΅ JAPAN

🌏 ASIA

IJR.AX was created on 2000-05-22 by iShares. The fund's investment portfolio concentrates primarily on small cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of small capitalisation US equities.

πŸ™Œ Performance (5Yr p.a)

12.16%

πŸ“Š Share price

$189.95 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ‡ΊπŸ‡Έ UNITED STATES

Compare
Add to watchlist